MedTrace Logo

Effect of Intake of Glycin Max (L.) Merr. Peel Extract on Body Fat and Body Weight

NCT02108691 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-05-22

Study results available
· View outcomes & findings →

Summary

The investigators performed a 8-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Glycin max (L.) Merr. peel extract on decrement of body fat. The investigators measured decrement of body fat parameters , including Body Fat Mass, Percent Body Fat, weight and BMI(body mass index), and monitored their blood pressure.

Conditions

Interventions

DIETARY_SUPPLEMENT

Glycin max(L.) Merr. peel extract

Glycin max(L.) Merr. peel extract (2.5g/day)

DIETARY_SUPPLEMENT

Placebo

Placebo (2.5g/day)

Sponsors & Collaborators

  • Hanyang University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02108691 on ClinicalTrials.gov